SFSIG
AGIO icon

San Francisco Sentry Investment Group’s Agios Pharmaceuticals AGIO Stock Holding History

San Francisco Sentry Investment Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-367
Closed -$13K – 668
2020
Q1 		$13K Hold
367
– – 0.01% 435
2019
Q4 		$18K Buy
367
+24
+7% +$907 0.01% 496
2019
Q3 		$11K Buy
343
+152
+80% +$6.29K 0.01% 538
2019
Q2 		$10K Hold
191
– – ﹤0.01% 550
2019
Q1 		$13K Buy
+191
New +$11.1K 0.01% 534

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

San Francisco Sentry Investment Group's AGIO Position: Q2 2020 in Review

San Francisco Sentry Investment Group sold out of Agios Pharmaceuticals (AGIO) in Q2 2020, closing a stake of 367 shares — an estimated $13K sold.

San Francisco Sentry Investment Group first reported a position in AGIO in Q1 2019 and held it in 5 quarters. The position peaked at $18K in Q4 2019. 216 funds tracked by Wall St. Rank hold AGIO as of Q2 2020.

  • San Francisco Sentry Investment Group reported no remaining Agios Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 367 Agios Pharmaceuticals shares in Q2 2020, an estimated $13K.
  • San Francisco Sentry Investment Group first reported a position in Agios Pharmaceuticals in Q1 2019 and held it in 5 quarters.
  • San Francisco Sentry Investment Group's Agios Pharmaceuticals position peaked at $18K in Q4 2019.
  • 216 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2020.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2020, filed 17 Jul 2020.